Kurian Allison W, Hartman Anne-Renee, Mills Meredith A, Ford James M, Daniel Bruce L, Plevritis Sylvia K
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305-5820, USA.
Health Expect. 2005 Sep;8(3):221-33. doi: 10.1111/j.1369-7625.2005.00333.x.
Prophylactic mastectomy (PM) is often considered, but variably chosen by women at high inherited risk of breast cancer; few data exist on patient tolerance of intensive breast screening as an alternative to PM. We performed an evaluation of high-risk women's tolerance of a breast screening protocol using clinical breast examination, mammography, breast magnetic resonance imaging (MRI) and ductal lavage (DL), and of change in attitudes toward PM after screening.
A questionnaire assessing tolerance of screening procedures and change in opinion towards PM was designed and administered to 43 study participants, after a median follow-up of 13 months. Responses were evaluated according to patient characteristics, including type of study-prompted interventions, BRCA mutation status, and prior history of cancer, via univariate analysis.
Most patients [85.3% (68.9-95.1%)] were more opposed or unchanged in their attitudes towards PM after study participation, with only 14.7% (5.0-31.1%) less opposed (P = 0.017) despite a short-interval follow-up MRI rate of 71.7% and a biopsy rate of 37%. Lower rates of maximal discomfort were reported with mammogram [2.8% (0-14.5%)] and MRI [5.6% (0-18.7%)] than with DL [28.6% (14.6-46.3%)], with P = 0.035.
Most high-risk women tolerated intensive breast screening well; they were not more inclined towards PM after participating. Future studies should prospectively evaluate larger numbers of high-risk women via multivariate analysis, to determine characteristics associated with preference for breast screening vs. PM.
预防性乳房切除术(PM)常被考虑,但乳腺癌高遗传风险女性对其选择各异;关于强化乳房筛查作为PM替代方案时患者耐受性的数据较少。我们对高危女性对一项乳房筛查方案(包括临床乳房检查、乳房X线摄影、乳房磁共振成像(MRI)和导管灌洗(DL))的耐受性,以及筛查后对PM态度的变化进行了评估。
设计了一份评估筛查程序耐受性和对PM看法变化的问卷,并在中位随访13个月后对43名研究参与者进行了问卷调查。通过单因素分析,根据患者特征(包括研究提示干预类型、BRCA突变状态和既往癌症史)对回答进行评估。
大多数患者[85.3%(68.9 - 95.1%)]在参与研究后对PM的态度更反对或无变化,尽管短间隔MRI率为71.7%,活检率为37%,但只有14.7%(5.0 - 31.1%)反对程度降低(P = 0.017)。与DL[28.6%(14.6 - 46.3%)]相比,乳房X线摄影[2.8%(0 - 14.5%)]和MRI[5.6%(0 - 18.7%)]报告的最大不适发生率较低,P = 0.035。
大多数高危女性对强化乳房筛查耐受性良好;参与研究后她们对PM的倾向并未增加。未来研究应通过多因素分析前瞻性评估更多高危女性,以确定与倾向乳房筛查而非PM相关的特征。